Proteome Sciences this week reported full-year 2012 revenues of £1.2 million ($1.8 million), up 13 percent from £1 million in 2011.

The increase was driven by a jump in license, sales, and service revenue, which rose 22 percent to £810,000 from £660,000 in 2011. Grant revenue was £350,000, down 3 percent from £360,000. Revenues from sales of the company's TMT isobaric tagging reagents were up 41 percent.

Cost of sales for 2012 increased 49 percent to £385,468 from £257,274, while administrative expenses fell 2 percent to £5 million from £5.1 million.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.

Jul
12
Sponsored by
Canon BioMedical

This webinar will discuss a project that is analyzing the “Human Brainome” – genome, transcriptome, proteome, and phenome interaction data -- to gain insights into Alzheimer’s disease pathogenesis.